Primary biliary cholangitis with contemporary presence of anti-mithocondrial and anti-rods and rings autoantibodies: literature first case
Gastroenterology and Hepatology from Bed to Bench,
Vol. 12 No. 1 (2019),
29 January 2019
,
Page 76-82
https://doi.org/10.22037/ghfbb.v0i0.1433
Abstract
Primary biliary cholangitis , previously known as primary biliary cirrhosis (PBC), is the most common autoimmune diseases of the liver (ALD). Patients with PBC may present with typical biliary pattern symptoms. Also the presence of anti mitochondrial autoantibodies (AMAs) is the laboratory hallmark of PBC, which molecular target antigens are members of 2-oxoacid dehydrogenase complex of enzymes.
In recent years, autoantibodies (Aab) targeting subcellular structures described as the rods and rings (R&R) pattern in HEp-2 ANA have been presented as a unique and particular case of Aab generation. These R&R structures are composed of inosine monophosphate dehydrogenase type 2 (IMPDH2), and their formation can be induced in vitro by several small-molecule inhibitors.
Aab targeting these relatively unknown structures have been almost exclusively observed in hepatitis C virus (HCV) patients who have undergone treatment with pegylated interferon-a/ribavirin (IFN/RBV) therapy. Literature showed that anti-RR Aab have not been found in treatment-naïve HCV patients or in patients from any other disease.
Now We present and characterized a case patient with contemporary presence of AMAs and R&R Aab in PBC, without any laboratory evidences of HCV and/or other hepatic virus infection.
For our knowledge this is the first case described in the Literature.
R&R Aab in patients without any clinical/laboratory signs or symptoms of Hepatitis virus and without pharmacological therapy open the window to the alternative scenario: the association of these Aab to ALD. The AMA-negative cases are an intriguing diagnostic problem. Our work demonstrated that R&R Aab can be present in PBC case. The interesting idea suggesting suggested that R&R Aab may be present also in AMA-negative PBC and they can considered a new diagnostic tool in this specific clinical condition.
Other study and cases are needed but the presence of R&R Aab linked with AMAs and PBC may be explained by alterations in immune regulation caused by autoimmunity in a particular genetic background.
- Primary biliary cholangitis
- rods and rings Autoantibodies
- Anti-Mithocondrial antibodies
- Autoimmune liver diseas
How to Cite
References
Koulentaki M, Mantaka A, Sifaki-Pistolla D, Thalassinos E, Tzanakis N, Kouroumalis E. Geoepidemiology and space-time analysis of primary biliary cirrhosis in Crete, Greece. Liver Int 2014;34:e200–7.
Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatol 2009;50: 291–308.
Yamagiwa S, Kamimura H, Takamura M, Aoyagi Y. Autoantibodies in primary biliary cirrhosis: recent progress in research on the pathogenetic and clinical significance. World J Gastroenterol 2014;20:2606–12.
Benson GD, Kikuchi K, Miyakawa H, Tanaka A, Watnik MR, Gershwin ME. Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis. Clin Dev Immunol 2004;11:129–133.
Calise SJ, Carcamo WC, Ceribelli A, Dominguez Y, Satoh M, Chan EK. Antibodies to rods and rings. In: Shoenfeld Y, Meroni PL, Gershwin ME, Eds. New York: Elsevier Science; 2014; pp. 161-168.
Carcamo WC, Ceribelli A, Calise SJ, Krueger C, Liu C, Daves M, et al. Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients. J Clin Immunol 2013;33:420-6.
Keppeke GD, Satoh M, Ferraz ML, Chan EK, Andrade LE. Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α. Immunol Res 2014;60:38-49.
Climent J, Morandeira F, Castellote J, Xiol J, Niubó J, Calatayud L, et al. Clinical correlates of the "rods and rings" antinuclear antibody pattern. Autoimmunity 2016;49:102-8.
McNally RJ, James PW, Ducker S, Norman PD, James OF. No rise in incidence but geographical heterogeneity in the occurrence of primary biliary cirrhosis in North East England. Am J Epidemiol 2014; 179: 492–98.
Invernizzi P, Battezzati PM, Crosignani A, Perego F, Poli F, Morabito A, et al. Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J Hepatol 2003;38:401-6.
Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet 2015;386:1565–75.
Han E, Jo SJ, Lee H, Choi AR, Lim J, Jung ES, et al. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis. Clin Chim Acta. 2017;464:113-7.
Carcamo WC, Calise SJ, von Mühlen CA, Satoh M, Chan EK. Molecular cell biology and immunobiology of mammalian rod/ring structures. Int Rev Cell Mol Biol. 2014;308:35-74.
Probst C, Radzimski C, Blöcker IM, Teegen B, Bogdanos DP, Stöcker W, et al. Development of a recombinant cell-based indirect immunofluorescence assay (RC-IFA) for the determination of autoantibodies against "rings and rods"-associated inosine-5'-monophosphate dehydrogenase 2 in viral hepatitis C.
Clin Chim Acta 2013;418:91-6.
Keppeke GD, Nunes E, Ferraz ML, Silva EA, Granato C, Chan EK, et al. Longitudinal study of a human drug-induced model of autoantibody to cytoplasmic rods/rings following HCV therapy with ribavirin and interferon-α. PLoS One
;7:e45392.
Shaikh Y, Krantz A, El-Farra Y. Anti-rods and rings autoantibodies can occur in the hepatitis c-naïve population. J Prev Med Hyg 2013;54:175-80.
Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 2000;47:85-118.
Seelig HP, Appelhans H, Bauer O, Blüthner M, Hartung K, Schranz P, et al. Autoantibodies against inosine-5'-monophosphate dehydrogenase 2--characteristics and prevalence in patients with HCV-infection. Clin Lab 2011;57:753-65.
Chan ES, Cronstein BN. Molecular action of methotrexate in inflammatory diseases. Arthritis Res 2002;4:266-73.
Climent J, Morandeira F, Castellote J, Xiol J, Niubó J, Calatayud L, et al. Clinical correlates of the "rods and rings" antinuclear antibody pattern. Autoimmunity 2016;49:102-8.
Granito A, Muratori P, Quarneti C, Pappas G, Cicola R, Muratori L. Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. Expert Rev Mol Diagn 2012;12:65–74.
Assandri R, Monari M, Montanelli A. Development of systemic sclerosis in patients with autoimmune hepatitis: an emerging overlap syndrome. Gastroenterol Hepatol Bed Bench 2016;9:211-9.
Valaperta S, Alpini C, Bottone MG, Monari M, Assandri R, Montanelli A. Autoanticorpi anti-Golgi: anche l’occhio vuole la sua parte. Recenti Prog Med 2011;102:11-3.
Assandri R, Serana F, Montanelli A. Development of PBC/SSc overlap syndrome in chronic GVHD patient: Immunological implications in the presence of mitochondrial, nucleolar and spindle midzone autoantigens. Gastroenterol Hepatol Bed Bench 2017;10:323-331.
- Abstract Viewed: 175 times
- PDF Downloaded: 108 times